Qin Xianhui, Li Youbao, Yuan Hui, Xie Di, Tang Genfu, Wang Binyan, Wang Xiaobin, Xu Xin, Xu Xiping, Hou Fanfan
From the National Clinical Research Center for Kidney Disease (XQ, YL, DX, BW, Xin X, Xiping X, FH); State Key Laboratory of Organ Failure Research (XQ, YL, DX, BW, Xin X, Xiping X, FH); Renal Division (XQ, YL, DX, BW, Xin X, Xiping X, FH), Nanfang Hospital, Southern Medical University, Guangzhou; Clinical Laboratory of Anzhen Hospital (HY), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing; Institute of Biomedicine (GT), Anhui Medical University, Hefei, China; and Center on the Early Life Origins of Disease (XW), Department of Population, Family and Reproductive Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland.
Medicine (Baltimore). 2015 Feb;94(7):e563. doi: 10.1097/MD.0000000000000563.
East Asian patients with diabetes have a higher risk for renal complications and strokes than Europeans. We aimed to evaluate the effect of methylenetetrahydrofolate reductase (MTHFR) gene 677 C → T polymorphism, which was associated with a higher stroke risk and was common in the Chinese population, as well as homocysteine and estimated glomerular filtration rate (eGFR) levels on the risk of new-onset diabetes (NOD). A total of 2422 subjects without diabetes were followed-up for 7 years. NOD was defined as fasting plasma glucose ≥ 7.0 mmol/L or self-reported physician diagnosis of diabetes. Compared with subjects with MTHFR 677 CC genotype, those with TT genotype had a higher risk of NOD in females (odds ratio 2.78, 95% confidence interval 1.39-5.56) but not in males (0.80, 0.40-1.61, P for interaction = 0.008). Furthermore, MTHFR 677 C → T polymorphism was more strongly associated with the risk of NOD among females with higher body mass index (BMI, ≥ 23 vs <23 kg/m(2), P for interaction = 0.009) or lower high-density lipoprotein-cholesterol (HDL-C, <1.3 vs ≥ 1.3 mmol/L, P for interaction = 0.015) levels. Hyperhomocysteinemia (≥ 16 vs <10 μmol/L) was not significantly associated with NOD in males (0.88, 0.42-1.85) or females (1.52, 0.65-3.57). However, mildly decreased eGFR (<90 vs 90-120 mL/min/1.73 m(2)) was associated with NOD mainly in males (1.96, 1.01-3.78; females, 0.74, 0.32-1.72, P for interaction = 0.134). Females with MTHFR 677 TT genotype had a significantly higher risk of NOD, particularly those with higher BMI or low HDL-C levels. The higher risk of NOD associated with mildly decreased eGFR also warrants more investigation. Our results provide insights into the ethnic differences of diabetic complications between East Asian patients and Europeans.
与欧洲人相比,东亚糖尿病患者发生肾脏并发症和中风的风险更高。我们旨在评估亚甲基四氢叶酸还原酶(MTHFR)基因677 C→T多态性(其与较高的中风风险相关且在中国人群中常见)以及同型半胱氨酸和估算肾小球滤过率(eGFR)水平对新发糖尿病(NOD)风险的影响。共有2422名无糖尿病的受试者接受了7年的随访。NOD定义为空腹血糖≥7.0 mmol/L或医生自我报告诊断为糖尿病。与MTHFR 677 CC基因型受试者相比,TT基因型受试者在女性中发生NOD的风险更高(比值比2.78,95%置信区间1.39 - 5.56),但在男性中并非如此(0.80,0.40 - 1.61,交互作用P值 = 0.008)。此外,MTHFR 677 C→T多态性在体重指数(BMI,≥23 vs <23 kg/m²,交互作用P值 = 0.009)较高或高密度脂蛋白胆固醇(HDL-C,<1.3 vs ≥1.3 mmol/L,交互作用P值 = 0.015)水平较低的女性中与NOD风险的关联更强。高同型半胱氨酸血症(≥16 vs <10 μmol/L)在男性(0.88,0.42 - 1.85)或女性(1.52,0.65 - 3.57)中与NOD无显著关联。然而,轻度降低的eGFR(<90 vs 90 - 120 mL/min/1.73 m²)主要在男性中与NOD相关(1.96,1.01 - 3.78;女性为0.74,0.32 - 1.72,交互作用P值 = 0.134)。MTHFR 677 TT基因型的女性发生NOD的风险显著更高,尤其是那些BMI较高或HDL-C水平较低的女性。与轻度降低的eGFR相关的NOD较高风险也值得进一步研究。我们的结果为东亚患者和欧洲人之间糖尿病并发症的种族差异提供了见解。